{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:54:05Z","timestamp":1761173645003,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.purol.2018.07.278","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T12:30:10Z","timestamp":1536150610000},"page":"839-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cons\u00e9quences sexuelles des traitements de l\u2019HBP"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Descazeaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"de La Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.purol.2018.07.278_bib0240","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","article-title":"Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"60","author":"Gacci","year":"2011","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2018.07.278_bib0245","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunc-tion: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"Rosen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0250","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0255","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1442-2042.2006.01535.x","article-title":"Ejaculatory disor-der caused by alpha-1\u00a0adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission","volume":"13","author":"Hisasue","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0090-4295(02)02114-3","article-title":"Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the prospective European doxazosin and combination therapy (PREDICT) trial","volume":"61","author":"Kirby","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.07.278_bib0265","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1464-410X.2005.05347.x","article-title":"Alfuzosin 10mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction","volume":"95","author":"van Moorselaar","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2018.07.278_bib0270","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000052361","article-title":"Efficacy and safety of a new prolonged release formulation of alfuzosin 10mg once daily versus alfuzosin 2.5mg thrice daily and placebo in patients with symptomatic benign prostatic hyperplasia","volume":"37","author":"van Kerrebroeck","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0275","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1464-410X.2005.05962.x","article-title":"Long-term efficacy and safety of alfuzosin 10mg once daily: a 2-year experience in \u201creal-life\u201d practice","volume":"97","author":"Elhilali","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2018.07.278_bib0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.urology.2013.03.026","article-title":"Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"82","author":"Shelbaia","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.purol.2018.07.278_bib0285","article-title":"Tamsulosin for benign prostatic hyperplasia","volume":"4","author":"Wilt","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.purol.2018.07.278_bib0290","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jsm.12039","volume":"10","author":"Giuliano","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2018.07.278_bib0295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bju.12712","article-title":"A pooled anal-ysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)","volume":"114","author":"Novara","year":"2014","journal-title":"BJU Int"},{"issue":"16","key":"10.1016\/j.purol.2018.07.278_bib0300","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.purol.2012.10.001","volume":"22","author":"Descazeaud","year":"2012","journal-title":"Prog Urol"},{"issue":"19","key":"10.1016\/j.purol.2018.07.278_bib0305","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men 669\u00a0with lower urinary tract symptoms and overactive bladder: a 670\u00a0randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.purol.2018.07.278_bib0310","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1464-410X.2012.11172.x","article-title":"Serenoa 672\u00a0repens monotherapy for benign prostatic hyperplasia 673 (BPH): an updated Cochrane systematic review","volume":"109","author":"MacDonald","year":"2012","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2018.07.278_bib0315","article-title":"Pygeum africanum for benign prostatic hyperplasia","author":"Wilt","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.purol.2018.07.278_bib0320","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.purol.2014.12.003","article-title":"Effets n\u00e9gatifs sur la sexualit\u00e9 des traitements m\u00e9dicamenteux des sympt\u00f4mes du bas appareil urinaire li\u00e9s a l\u2019hypertrophie b\u00e9nigne de la prostate","volume":"25","author":"Descazeaud","year":"2015","journal-title":"Prog Urol"},{"issue":"3","key":"10.1016\/j.purol.2018.07.278_bib0325","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ucl.2016.04.010","article-title":"Sexual side effects of medical and surgical benign prostatic hyperplasia treatments","volume":"43","author":"Welliver","year":"2016","journal-title":"Urol Clin North Am"},{"issue":"6","key":"10.1016\/j.purol.2018.07.278_bib0330","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.juro.2013.12.014","article-title":"Change in sexual function in men with lower urinary tract symp-toms\/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy","volume":"191","author":"Fwu","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2018.07.278_bib0335","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/andr.12353","article-title":"Sexual dysfunction in subjects treated with inhibitors of 5\u03b1-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis","volume":"5","author":"Corona","year":"2017","journal-title":"Andrology"},{"key":"10.1016\/j.purol.2018.07.278_bib0340","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0090-4295(02)02401-9","article-title":"Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia","volume":"61","author":"Wessels","year":"2003","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2018.07.278_bib0345","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1743-6109.2010.02157.x","article-title":"Adverse side effects of 5\u03b1-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients","volume":"8","author":"Traish","year":"2011","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2018.07.278_bib0350","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/j.1743-6109.2007.00563.x","article-title":"Finasteride 5mg and sexual side effects: how many of these are related to a nocebo phenomenon?","volume":"4","author":"Mondaini","year":"2007","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2018.07.278_bib0355","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.purol.2018.07.278_bib0360","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bju.12868","article-title":"Ejaculatory dysfunction after treatment for lower urinary tract symptoms: retrograde ejaculation or retrograde thinking?","volume":"115","author":"Sturch","year":"2015","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2018.07.278_bib0365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2018.07.278_bib0370","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.urology.2007.02.036","article-title":"Development and validation of four-item version of male sexual health questionnaire to assess ejaculatory dysfunction","volume":"69","author":"Rosen","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.purol.2018.07.278_bib0375","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/iju.12866","article-title":"Systematic review of lower urinary tract symptoms\/benign prostatic hyperplasia surgical treatments on men's ejaculatory function: time for a bespoke approach?","volume":"23","author":"Marra","year":"2016","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.purol.2018.07.278_bib0380","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ijir.2009.56","article-title":"Effect of transurethral resection of the prostate on erectile function: a prospective comparative study","volume":"22","author":"Jaidane","year":"2010","journal-title":"Int J Impot Res"},{"issue":"1","key":"10.1016\/j.purol.2018.07.278_bib0385","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1745-7262.2006.00088.x","article-title":"Erectile dysfunction after transurethral prostatectomy for lower urinary tract symptoms: results from a center with over 500\u00a0patients","volume":"8","author":"Poulakis","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1016\/j.purol.2018.07.278_bib0390","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2007.01.088","article-title":"Sexual func-tion after transurethral resection of the prostate (TURP): results of an independent prospective multi- centre assessment of outcome","volume":"52","author":"Muntener","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0395","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM199501123320202","article-title":"A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia: the veterans affairs cooperative study group on transurethral resection of the prostate","volume":"332","author":"Wasson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2018.07.278_bib0400","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1464-410X.1993.tb00686.x","article-title":"The pros-tatron transurethral microwave device in the treat-ment of bladder outflow obstruction due to benign prostatic hyperplasia","volume":"72","author":"Kirby","year":"1993","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0405","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-5347(01)61930-X","article-title":"Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermo-therapy to transurethral prostatic resection","volume":"161","author":"Francisca","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0410","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/08927790360587432","article-title":"Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18\u00a0months","volume":"17","author":"Cimentepe","year":"2003","journal-title":"J Endourol"},{"key":"10.1016\/j.purol.2018.07.278_bib0415","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0022-5347(05)67142-X","article-title":"Impact of interven-tional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study","volume":"164","author":"Arai","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0420","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jsm.12333","article-title":"Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift","volume":"11","author":"McVary","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2018.07.278_bib0425","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2014.10.031","article-title":"Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"67","author":"Perera","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2018.07.278_bib0430","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1464-410X.2003.04072.x","article-title":"Urinary symp-toms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study","volume":"91","author":"Gacci","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2018.07.278_bib0435","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1464-410X.2011.10359.x","article-title":"Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7\u00a0years","volume":"109","author":"Gilling","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2018.07.278_bib0440","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0022-5347(05)00983-3","article-title":"Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial","volume":"175","author":"Briganti","year":"2006","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2018.07.278_bib0445","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2010.04.027","article-title":"Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149\u00a0patients with long-term follow-up","volume":"58","author":"Bruy\u00e8re","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2018.07.278_bib0450","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","article-title":"Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis","volume":"39","author":"Carnevale","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"10.1016\/j.purol.2018.07.278_bib0455","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00270-015-1267-0","article-title":"Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study","volume":"39","author":"Amouyal","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"10.1016\/j.purol.2018.07.278_bib0460","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00270-016-1539-3","article-title":"A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia","volume":"40","author":"Kuang","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"10.1016\/j.purol.2018.07.278_bib0465","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.juro.2016.12.045","article-title":"Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"197","author":"Roehrborn","year":"2017","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2018.07.278_bib0470","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","article-title":"Water \u2013 a double-blind randomized controlled trial of aquablation\u00ae vs. transurethral resection of the prostate in benign prostatic hyperplasia","volume":"199","author":"Gilling","year":"2018","journal-title":"J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718304561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718304561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:30:54Z","timestamp":1761114654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708718304561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":47,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1166708718304561"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2018.07.278","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cons\u00e9quences sexuelles des traitements de l\u2019HBP","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2018.07.278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}